Literature DB >> 30305391

The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2.

Mónica Ferreira1, Iris Verbinnen2, Margarida Fardilha3, Aleyde Van Eynde4, Mathieu Bollen5.   

Abstract

Germ cell proliferation is epigenetically controlled, mainly through DNA methylation and histone modifications. However, the pivotal epigenetic regulators of germ cell self-renewal and differentiation in postnatal testis are still poorly defined. The histone methyltransferase enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of Polycomb repressive complex 2, represses target genes through trimethylation of histone H3 at Lys-27 (H3K27me3), and interacts (in)directly with both protein phosphatase 1 (PP1) and nuclear inhibitor of PP1 (NIPP1). Here, we report that postnatal, testis-specific ablation of NIPP1 in mice results in loss of EZH2 and reduces H3K27me3 levels. Mechanistically, the NIPP1 deletion abrogated PP1-mediated EZH2 dephosphorylation at two cyclin-dependent kinase sites (Thr-345/487), thereby generating hyperphosphorylated EZH2, which is a substrate for proteolytic degradation. Accordingly, alanine mutation of these residues prolonged the half-life of EZH2 in male germ cells. Our study discloses a key role for the PP1:NIPP1 holoenzyme in stabilizing EZH2 and maintaining the H3K27me3 mark on genes that are important for germ cell development and spermatogenesis.
© 2018 Ferreira et al.

Entities:  

Keywords:  EZH2; NIPP1; PRC2; Polycomb group; RBAP48; SUZ12; cell cycle; chromatin; enhancer of zeste homolog 2; epigenetics; germ cells; histone methylation; phosphoprotein phosphatase 1 (PP1); protein phosphatase 1; protein phosphorylation; protein stability; proteolysis; spermatogenesis; testis

Mesh:

Substances:

Year:  2018        PMID: 30305391      PMCID: PMC6254331          DOI: 10.1074/jbc.AC118.005577

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers.

Authors:  Cheng-Chieh Yang; Adam LaBaff; Yongkun Wei; Lei Nie; Weiya Xia; Longfei Huo; Hirohito Yamaguchi; Yi-Hsin Hsu; Jennifer L Hsu; Dongping Liu; Jingyu Lang; Yi Du; Huang-Chun Lien; Long-Yuan Li; Rong Deng; Li-Chuan Chan; Jun Yao; Celina G Kleer; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

Review 2.  Polycomb silencers control cell fate, development and cancer.

Authors:  Anke Sparmann; Maarten van Lohuizen
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

3.  The transcriptional repression by NIPP1 is mediated by Polycomb group proteins.

Authors:  Nivedita Roy; Aleyde Van Eynde; Lijs Beke; Mieke Nuytten; Mathieu Bollen
Journal:  Biochim Biophys Acta       Date:  2007-08-08

Review 4.  The PP1 binding code: a molecular-lego strategy that governs specificity.

Authors:  Ewald Heroes; Bart Lesage; Janina Görnemann; Monique Beullens; Luc Van Meervelt; Mathieu Bollen
Journal:  FEBS J       Date:  2012-03-21       Impact factor: 5.542

5.  Revolution in the Polycomb hierarchy.

Authors:  Itys Comet; Kristian Helin
Journal:  Nat Struct Mol Biol       Date:  2014-07       Impact factor: 15.369

6.  Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA.

Authors:  Syuzo Kaneko; Gang Li; Jinsook Son; Chong-Feng Xu; Raphael Margueron; Thomas A Neubert; Danny Reinberg
Journal:  Genes Dev       Date:  2010-12-01       Impact factor: 11.361

7.  The protein phosphatase-1 (PP1) regulator, nuclear inhibitor of PP1 (NIPP1), interacts with the polycomb group protein, embryonic ectoderm development (EED), and functions as a transcriptional repressor.

Authors:  Qiming Jin; Aleyde van Eynde; Monique Beullens; Nivedita Roy; Gerald Thiel; Willy Stalmans; Mathieu Bollen
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

8.  Nuclear inhibitor of protein phosphatase-1 (NIPP1) directs protein phosphatase-1 (PP1) to dephosphorylate the U2 small nuclear ribonucleoprotein particle (snRNP) component, spliceosome-associated protein 155 (Sap155).

Authors:  Nobuhiro Tanuma; Sei-Eun Kim; Monique Beullens; Yao Tsubaki; Shinya Mitsuhashi; Miyuki Nomura; Takeshi Kawamura; Kyoichi Isono; Haruhiko Koseki; Masami Sato; Mathieu Bollen; Kunimi Kikuchi; Hiroshi Shima
Journal:  J Biol Chem       Date:  2008-10-08       Impact factor: 5.157

9.  Repression of the soma-specific transcriptome by Polycomb-repressive complex 2 promotes male germ cell development.

Authors:  Weipeng Mu; Joshua Starmer; Andrew M Fedoriw; Della Yee; Terry Magnuson
Journal:  Genes Dev       Date:  2014-09-15       Impact factor: 11.361

10.  The protein phosphatase 1 regulator NIPP1 is essential for mammalian spermatogenesis.

Authors:  Mónica Ferreira; Shannah Boens; Claudia Winkler; Kathelijne Szekér; Iris Verbinnen; Aleyde Van Eynde; Margarida Fardilha; Mathieu Bollen
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

View more
  4 in total

1.  Role of Protein Phosphatase1 Regulatory Subunit3 in Mediating the Abscisic Acid Response.

Authors:  Jing Zhang; Qianqian Qin; Xiaohui Nan; Zilong Guo; Yang Liu; Sawaira Jadoon; Yan Chen; Lulu Zhao; Longfeng Yan; Suiwen Hou
Journal:  Plant Physiol       Date:  2020-09-18       Impact factor: 8.340

2.  Phosphatase Regulator NIPP1 Restrains Chemokine-Driven Skin Inflammation.

Authors:  Iris Verbinnen; Marloes Jonkhout; Kifayathullah Liakath-Ali; Kathelijne Szekér; Mónica Ferreira; Shannah Boens; Raphael Rouget; Margareta Nikolic; Susan Schlenner; Aleyde Van Eynde; Mathieu Bollen
Journal:  J Invest Dermatol       Date:  2020-01-21       Impact factor: 8.551

3.  FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.

Authors:  Malin Lindén; Christer Thomsen; Pernilla Grundevik; Emma Jonasson; Daniel Andersson; Rikard Runnberg; Soheila Dolatabadi; Christoffer Vannas; Manuel Luna Santamarίa; Henrik Fagman; Anders Ståhlberg; Pierre Åman
Journal:  EMBO Rep       Date:  2019-04-08       Impact factor: 8.807

Review 4.  Post-translational modifications of EZH2 in cancer.

Authors:  Zhongwei Li; Minle Li; Diandian Wang; Pingfu Hou; Xintian Chen; Sufang Chu; Dafei Chai; Junnian Zheng; Jin Bai
Journal:  Cell Biosci       Date:  2020-12-11       Impact factor: 7.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.